Lineage Cell Therapeutics, Inc. (LCTX)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 08, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 07:30
Lineage Cell Therapeutics Debt to Equity Ratio : 0.0377 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0377 |
| March 31, 2026 | 0.0444 |
| December 31, 2025 | 0.0543 |
| September 30, 2025 | 0.1189 |
| June 30, 2025 | 0.0445 |
| March 31, 2025 | 0.0284 |
| December 31, 2024 | 0.0321 |
| September 30, 2024 | 0.0415 |
| June 30, 2024 | 0.0432 |
| March 31, 2024 | 0.0449 |
| December 31, 2023 | 0.0465 |
| September 30, 2023 | 0.0452 |
| June 30, 2023 | 0.0468 |
| March 31, 2023 | 0.0516 |
| December 31, 2022 | 0.0531 |
| September 30, 2022 | 0.0355 |
| June 30, 2022 | 0.0253 |
| March 31, 2022 | 0.0295 |
| December 31, 2021 | 0.0304 |
| September 30, 2021 | 0.0225 |
| June 30, 2021 | 0.0233 |
| March 31, 2021 | 0.0302 |
| December 31, 2020 | 0.0343 |
| September 30, 2020 | 0.0254 |
| June 30, 2020 | 0.046 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0454 |
| December 31, 2019 | 0.0458 |
| September 30, 2019 | 0.0453 |
| June 30, 2019 | 0.0365 |
| March 31, 2019 | 0.0313 |
| December 31, 2018 | 0.0241 |
| September 30, 2018 | 0.0095 |
| June 30, 2018 | 0.0136 |
| March 31, 2018 | 0.0143 |
| December 31, 2017 | 0.0032 |
| September 30, 2017 | 0.0009 |
| June 30, 2017 | 0.0158 |
| March 31, 2017 | 0.0126 |
| December 31, 2016 | 0.022 |
| September 30, 2016 | 0.0154 |
| June 30, 2016 | 0.0147 |
| March 31, 2016 | 0.0703 |
| December 31, 2015 | 0.0261 |
| September 30, 2015 | 0.0509 |
| June 30, 2015 | 0.0176 |
| March 31, 2015 | 0.0307 |
| December 31, 2014 | 0.0041 |
| September 30, 2014 | 0.0096 |
| June 30, 2014 | 0.0064 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 106.22M |
| Total Liabilities (Quarterly) | 46.42M |
| Shareholders Equity (Quarterly) | 60.92M |
| Current Ratio | 6.608 |
| Net Debt Paydown Yield | 0.00% |